COMGEN BIOPHARMACEUTICAL
Kangjing Bio focuses on the research and development of innovative drugs for the immunotherapy of autoimmune diseases and tumors. A round of financing of nearly 100 million yuan has been completed. This round of financing was jointly led by Sequoia China and Yahui Investment, followed by Fuchuang Investment and Renyou Investment. For this transaction, Hejun Capital and Chenrui Capital acted as financial advisors. This round of financing will be mainly used for phase I clinical trials of complement inhibitors under research on new targets, the advancement of other pipeline drugs, and the further consolidation of the application of innovative drug research and development platforms based on the complement system.
COMGEN BIOPHARMACEUTICAL
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2017-06-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.comgenpharma.com
Total Employee:
11+
Status:
Active
Contact:
+86-21-68822018
Email Addresses:
[email protected]
Total Funding:
0
Similar Organizations
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Investors List
Yahui Precision Medicine Fund
Yahui Precision Medicine Fund investment in Series A - ComGen Biopharmaceutical
Fudan Venture Capital
Fudan Venture Capital investment in Series A - ComGen Biopharmaceutical
Sequoia Capital China
Sequoia Capital China investment in Series A - ComGen Biopharmaceutical
Official Site Inspections
http://www.comgenpharma.com
- Host name: 120.133.60.61
- IP address: 120.133.60.61
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
